147 related articles for article (PubMed ID: 7811051)
1. In vitro activity of dirithromycin against Chlamydia trachomatis.
Segreti J; Kapell KS
Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of dirithromycin against Chlamydia pneumoniae.
Roblin PM; Kutlin A; Sokolovskaya N; Hammerschlag MR
J Antimicrob Chemother; 1997 May; 39(5):647-9. PubMed ID: 9184366
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
Welsh LE; Gaydos CA; Quinn TC
Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.
Counter FT; Ensminger PW; Preston DA; Wu CY; Greene JM; Felty-Duckworth AM; Paschal JW; Kirst HA
Antimicrob Agents Chemother; 1991 Jun; 35(6):1116-26. PubMed ID: 1929252
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species.
Rennie KA; Prasad ES; Wenman WM
Diagn Microbiol Infect Dis; 1994 Sep; 20(1):57-9. PubMed ID: 7867300
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of azithromycin against Chlamydia trachomatis.
Scieux C; Bianchi A; Chappey B; Vassias I; Pérol Y
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():7-10. PubMed ID: 2154440
[TBL] [Abstract][Full Text] [Related]
8. Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.
Barry AL; Pfaller MA; Fuchs PC
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():27-37. PubMed ID: 8478310
[TBL] [Abstract][Full Text] [Related]
9. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
Shinkai I; Ohta Y
Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
Segreti J; Kessler HA; Kapell KS; Trenholme GM
Antimicrob Agents Chemother; 1987 Jan; 31(1):100-1. PubMed ID: 2952061
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
12. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation.
Abdelghaffar H; Mtairag EM; Labro MT
Antimicrob Agents Chemother; 1994 Jul; 38(7):1548-54. PubMed ID: 7979287
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of a new quinolone, NM 394, against Chlamydia trachomatis].
Poutiers F; de Barbeyrac B; Garcia-Mace J; Bebear C
Pathol Biol (Paris); 1996 May; 44(5):351-4. PubMed ID: 8758474
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R
J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
Segreti J; Kapell KS; Trenholme GM
Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
18. Multi-centre collaborative study for the in vitro evaluation of new macrolides dirithromycin and erythromycylamine. Australian Group for Antimicrobial Resistance (AGAR).
Fernandes CJ; Benn RA; Nimmo GR
Pathology; 1995 Jan; 27(1):74-8. PubMed ID: 7603759
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis: in vitro susceptibility to antibiotics singly and in combination.
Christensen JJ; Holten-Andersen W; Nielsen PB
Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):329-32. PubMed ID: 3788573
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
